GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAF) » Definitions » EBITDA Margin %

Elekta AB (Elekta AB) EBITDA Margin % : 18.73% (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is Elekta AB EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Elekta AB's EBITDA for the three months ended in Jan. 2024 was $82 Mil. Elekta AB's Revenue for the three months ended in Jan. 2024 was $438 Mil. Therefore, Elekta AB's EBITDA margin for the quarter that ended in Jan. 2024 was 18.73%.


Elekta AB EBITDA Margin % Historical Data

The historical data trend for Elekta AB's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB EBITDA Margin % Chart

Elekta AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.76 20.16 22.28 18.48 14.74

Elekta AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.90 13.66 18.89 18.11 18.73

Competitive Comparison of Elekta AB's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Elekta AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elekta AB's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Elekta AB's EBITDA Margin % falls into.



Elekta AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Elekta AB's EBITDA Margin % for the fiscal year that ended in Apr. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Apr. 2023 )/Revenue (A: Apr. 2023 )
=240.23/1630.107
=14.74 %

Elekta AB's EBITDA Margin % for the quarter that ended in Jan. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=82.052/437.964
=18.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elekta AB  (OTCPK:EKTAF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Elekta AB EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Elekta AB's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Elekta AB (Elekta AB) Business Description

Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.